Efficacy of Baricitinib in Patients With Different Degrees of Severe Alopecia Areata: 52-Week Results From BRAVE-AA1 and BRAVE-AA2

    June 2023 in “ British Journal of Dermatology ”
    Paul Farrant, Alexander Egeberg, Taisuke Ito … Yu‐Huei Huang
    Studysummary In this study, baricitinib showed promising results in improving scalp, eyebrow, and eyelash hair loss in adults with severe and very severe alopecia areata over 52 weeks.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Related research 5

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019
    2. Oral Tofacitinib: A Promising Treatment in Atopic Dermatitis, Alopecia Areata, and Vitiligo Clinical and Experimental Dermatology · 2017
    3. Methotrexate for the Treatment of Pediatric Alopecia Areata Journal of dermatological treatment · 2017
    4. Vitiligo After Diphencyprone for Alopecia Areata Dermatology Research and Practice · 2010
    5. Severe Alopecia Areata Treated With Systemic Corticosteroids International Journal of Dermatology · 1998